---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-078255"
form_type: "8-K"
ticker: null
cik: "0001832415"
company_name: "Better Therapeutics, Inc."
filed_at: "2023-03-24T23:59:59+00:00"
generated_at: "2026-06-17T17:05:32.585298+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Better Therapeutics cuts 35% of workforce to extend cash runway ahead of FDA decision for BT-001

## Summary
- Workforce reduction of approx 35% of employees, effective March 24, 2023.
- Company estimates ~$400k in cash-based severance and benefits expenses in Q2 2023.
- CEO Frank Karbe cites need to preserve cash for potential FDA marketing authorization and commercial launch of BT-001.
- Actions taken due to industry volatility and to extend cash runway for critical milestones.

## SEC filing metadata
- accession: 0001193125-23-078255
- form_type: 8-K
- cik: 0001832415
- company_name: Better Therapeutics, Inc.
- filed_at: 2023-03-24T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.05, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832415/000119312523078255/0001193125-23-078255-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832415/000119312523078255/d484269d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-078255
- JSON: https://secwatch.observer/filing/0001193125-23-078255.json
- Plain text: https://secwatch.observer/filing/0001193125-23-078255.txt

## Key facts
- Restructurings & Charges
  Better Therapeutics, Inc. announced a restructuring with charges of approximately $400 thousand (approximately 35% of its employees).
  - Type: restructuring
  - Charge: approximately $400 thousand
  - Headcount: approximately 35% of its employees
  source text: On March 23 2023, Better Therapeutics, Inc. (the “Company”) announced a reduction in its workforce (the “Workforce Reduction”) of approximately 35% of its employees as part of a cost reduction initiative to improve its cash runway and focus on the long-term success of the company. The Company will complete this Workforce Reduction on March 24, 2023. The Company estimates that it will incur approximately $400 thousand in cash-based expenses related to severance and benefits in the second quarter of 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832415/000119312523078255/0001193125-23-078255-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.